U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.
Industry, Sector and Symbol
Industry Health services
Sub-IndustryHealth Care Facilities
SectorMedical
Phone713-297-7000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$453.91 million
Profitability
Miscellaneous
Employees4,300
Next Earnings Date5/2/2019 (Estimated)
OptionableOptionable
U.S. Physical Therapy (NYSE:USPH) Frequently Asked Questions
What is U.S. Physical Therapy's stock symbol?
U.S. Physical Therapy trades on the New York Stock Exchange (NYSE) under the ticker symbol "USPH."
How often does U.S. Physical Therapy pay dividends? What is the dividend yield for U.S. Physical Therapy?
U.S. Physical Therapy declared a quarterly dividend on Friday, March 8th. Investors of record on Wednesday, March 20th will be given a dividend of $0.27 per share on Friday, April 19th. This represents a $1.08 annualized dividend and a yield of 1.03%. The ex-dividend date is Tuesday, March 19th. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.23. View U.S. Physical Therapy's Dividend History.
How were U.S. Physical Therapy's earnings last quarter?
U.S. Physical Therapy, Inc. (NYSE:USPH) issued its quarterly earnings data on Thursday, March, 7th. The company reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of $0.63 by $0.08. The business earned $117.30 million during the quarter, compared to analyst estimates of $116.70 million. U.S. Physical Therapy had a return on equity of 18.76% and a net margin of 5.07%. The company's revenue for the quarter was up 7.4% on a year-over-year basis. View U.S. Physical Therapy's Earnings History.
When is U.S. Physical Therapy's next earnings date?
What guidance has U.S. Physical Therapy issued on next quarter's earnings?
U.S. Physical Therapy updated its FY 2019 earnings guidance on Thursday, March, 7th. The company provided EPS guidance of $2.76-2.85 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.80. The company issued revenue guidance of $35.1-36.4 million, compared to the consensus revenue estimate of $480.84 million.
What price target have analysts set for USPH?
5 brokerages have issued 1-year target prices for U.S. Physical Therapy's stock. Their predictions range from $105.00 to $107.00. On average, they anticipate U.S. Physical Therapy's stock price to reach $106.2033 in the next twelve months. This suggests a possible upside of 1.2% from the stock's current price. View Analyst Price Targets for U.S. Physical Therapy.
What is the consensus analysts' recommendation for U.S. Physical Therapy?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for U.S. Physical Therapy in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for U.S. Physical Therapy.
What are Wall Street analysts saying about U.S. Physical Therapy stock?
Here are some recent quotes from research analysts about U.S. Physical Therapy stock:
- 1. According to Zacks Investment Research, "U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders. " (2/9/2019)
- 2. Barrington Research analysts commented, "We are maintaining our MARKET PERFORM investment rating on USPH shares due to valuation concerns. This is genuinely frustrating because we continue to really like this business and its management team. That said, to hold a constructive investment rating on USPH shares, we would need to assign more than a 23.5x EV/EBITDA multiple to our 2019 estimate. As much as we like the company, such a valuation seems a bit much." (8/3/2018)
- 3. Cantor Fitzgerald analysts commented, "1Q18 results were in-line with our expectations, driven by a 7.4% jump in patient visits, new practices and a full quarter’s contribution from its workforce performance solutions business." (5/3/2018)
Has U.S. Physical Therapy been receiving favorable news coverage?
News articles about USPH stock have trended neutral this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. U.S. Physical Therapy earned a news impact score of 0.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an impact on the stock's share price in the immediate future.
Who are some of U.S. Physical Therapy's key competitors?
Some companies that are related to U.S. Physical Therapy include DiaSorin (DSRLF), United Therapeutics (UTHR), GALAPAGOS NV/S (GLPG), GW Pharmaceuticals PLC- (GWPH), Chemed (CHE), Ascendis Pharma A/S (ASND), Syneos Health (SYNH), Healthequity (HQY), Hikma Pharmaceuticals (HKMPF), NMC Health (NMC), Array Biopharma (ARRY), ORION OYJ/ADR (ORINY), Cronos Group (CRON), Medidata Solutions (MDSO) and ICU Medical (ICUI).
What other stocks do shareholders of U.S. Physical Therapy own?
Who are U.S. Physical Therapy's key executives?
U.S. Physical Therapy's management team includes the folowing people:
- Mr. Christopher J. Reading, Pres, CEO & Director (Age 55)
- Mr. Lawrance W. McAfee, Exec. VP, CFO & Director (Age 64)
- Mr. Glenn D. McDowell, Chief Operating Officer of West (Age 62)
- Mr. Graham Reeve M.B.A., P.T., Chief Operating Officer of East (Age 55)
- Mr. Jon C. Bates, VP & Corp. Controller
Who are U.S. Physical Therapy's major shareholders?
U.S. Physical Therapy's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.53%), Kayne Anderson Rudnick Investment Management LLC (10.97%), Dimensional Fund Advisors LP (3.89%), Riverbridge Partners LLC (3.59%), Standard Life Aberdeen plc (2.56%) and Northern Trust Corp (1.70%). Company insiders that own U.S. Physical Therapy stock include Bernard A Harris Jr, Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Harry S Chapman, Jerald L Pullins, Lawrance W Mcafee, Mark J Brookner and Regg E Swanson. View Institutional Ownership Trends for U.S. Physical Therapy.
Which major investors are selling U.S. Physical Therapy stock?
USPH stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Royce & Associates LP, BTIM Corp., Standard Life Aberdeen plc, Riverbridge Partners LLC, First Trust Advisors LP, Hancock Whitney Corp and Scout Investments Inc.. Company insiders that have sold U.S. Physical Therapy company stock in the last year include Christopher J Reading, Clayton Trier, Edward L Kuntz, Glenn Mcdowell, Jerald L Pullins, Lawrance W Mcafee and Mark J Brookner. View Insider Buying and Selling for U.S. Physical Therapy.
Which major investors are buying U.S. Physical Therapy stock?
USPH stock was purchased by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, BlackRock Inc., Bank of America Corp DE, Acadian Asset Management LLC, Martingale Asset Management L P, Geode Capital Management LLC, Geode Capital Management LLC and Bessemer Group Inc.. Company insiders that have bought U.S. Physical Therapy stock in the last two years include Harry S Chapman and Regg E Swanson. View Insider Buying and Selling for U.S. Physical Therapy.
How do I buy shares of U.S. Physical Therapy?
Shares of USPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is U.S. Physical Therapy's stock price today?
One share of USPH stock can currently be purchased for approximately $104.99.
How big of a company is U.S. Physical Therapy?
U.S. Physical Therapy has a market capitalization of $1.34 billion and generates $453.91 million in revenue each year. The company earns $34.87 million in net income (profit) each year or $2.65 on an earnings per share basis. U.S. Physical Therapy employs 4,300 workers across the globe.
What is U.S. Physical Therapy's official website?
How can I contact U.S. Physical Therapy?
U.S. Physical Therapy's mailing address is 1300 WEST SAM HOUSTON PARKWAY SUITE 300, HOUSTON TX, 77042. The company can be reached via phone at 713-297-7000 or via email at [email protected]
MarketBeat Community Rating for U.S. Physical Therapy (NYSE USPH)
MarketBeat's community ratings are surveys of what our community members think about U.S. Physical Therapy and other stocks. Vote "Outperform" if you believe USPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
